271 related articles for article (PubMed ID: 25645106)
1. Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.
Arcangeli S; Agolli L; Portalone L; Migliorino MR; Lopergolo MG; Monaco A; Dognini J; Pressello MC; Bracci S; Donato V
Br J Radiol; 2015 Apr; 88(1048):20140728. PubMed ID: 25645106
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours.
Arcangeli S; Falcinelli L; Bracci S; Greco A; Monaco A; Dognini J; Chiostrini C; Bellavita R; Aristei C; Donato V
Br J Radiol; 2017 Mar; 90(1071):20160853. PubMed ID: 28256158
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.
Casutt A; Bouchaab H; Beigelman-Aubry C; Bourhis J; Lovis A; Matzinger O
Br J Radiol; 2015 May; 88(1049):20140687. PubMed ID: 25735428
[TBL] [Abstract][Full Text] [Related]
4. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?
Kimura T; Matsuura K; Murakami Y; Hashimoto Y; Kenjo M; Kaneyasu Y; Wadasaki K; Hirokawa Y; Ito K; Okawa M
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):483-91. PubMed ID: 16904838
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
6. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
[TBL] [Abstract][Full Text] [Related]
7. Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes.
Linda A; Trovo M; Bradley JD
Eur J Radiol; 2011 Jul; 79(1):147-54. PubMed ID: 19954913
[TBL] [Abstract][Full Text] [Related]
8. Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience.
Figlia V; Mazzola R; Cuccia F; Alongi F; Mortellaro G; Cespuglio D; Cucchiara T; Iacoviello G; Valenti V; Molino M; Verderame F; Matranga D; Casto AL; Ferrera G
Radiol Med; 2018 Jun; 123(6):406-414. PubMed ID: 29455424
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study.
Guckenberger M; Heilman K; Wulf J; Mueller G; Beckmann G; Flentje M
Radiother Oncol; 2007 Dec; 85(3):435-42. PubMed ID: 18053602
[TBL] [Abstract][Full Text] [Related]
10. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
[TBL] [Abstract][Full Text] [Related]
11. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
[TBL] [Abstract][Full Text] [Related]
12. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
[TBL] [Abstract][Full Text] [Related]
13. Radiological assessment after stereotactic body radiation of lung tumours.
Chassagnon G; Martini K; Giraud P; Revel MP
Cancer Radiother; 2020 Aug; 24(5):379-387. PubMed ID: 32534799
[TBL] [Abstract][Full Text] [Related]
14. Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Dahele M; Palma D; Lagerwaard F; Slotman B; Senan S
J Thorac Oncol; 2011 Jul; 6(7):1221-8. PubMed ID: 21623237
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.
Taremi M; Hope A; Dahele M; Pearson S; Fung S; Purdie T; Brade A; Cho J; Sun A; Bissonnette JP; Bezjak A
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):967-73. PubMed ID: 21377293
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
Baumann P; Nyman J; Hoyer M; Gagliardi G; Lax I; Wennberg B; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JS; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
Radiother Oncol; 2008 Sep; 88(3):359-67. PubMed ID: 18768228
[TBL] [Abstract][Full Text] [Related]
17. Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
Takeda A; Kunieda E; Fujii H; Yokosuka N; Aoki Y; Oooka Y; Oku Y; Ohashi T; Sanuki N; Mizuno T; Ozawa Y
Lung Cancer; 2013 Mar; 79(3):248-53. PubMed ID: 23246123
[TBL] [Abstract][Full Text] [Related]
18. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques.
Palma DA; Senan S; Haasbeek CJ; Verbakel WF; Vincent A; Lagerwaard F
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):506-13. PubMed ID: 20584582
[TBL] [Abstract][Full Text] [Related]
19. Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy.
Ye L; Zhang Y; Li T; Zhang X; Shi S; Zhao Q; Zeng Z; He J
J Radiat Res; 2019 May; 60(3):371-379. PubMed ID: 30968939
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
